DePuy Synthes declined 7.5% in 1Q20 due to the impact of the COVID-19 pandemic, with the worst expected to come in 2Q as procedures are deferred en masse.
NuVasive voluntarily issued an Urgent Field Safety Notice in the U.K. and Ireland to address concerns identified by The Medicines and Healthcare Products Regulatory Agency over continued use of the MAGEC device for the treatment of scoliosis.
The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to keep you abreast of ways that competitors and customers are reacting to COVID-19.
After consulting with a host of industry veterans and observers, our guidance recommends that you expect and plan for business disruptions and revenue declines across the board—all companies, all market segments.
Regenerative medicine is an emerging market with solutions to not only heal but also grow tissue and bone. Renovos is addressing the issue of biological molecule diffusion through a synthetic nanoclay gel technology platform called Renovite.
The “wait and see” period for enabling technology in orthopedics is over. Commentary from executives and spending patterns of the largest orthopedic companies affirmed that message in the first three months of 2020.